Table 3 Clinical variables in 441 lung adenocarcinoma patients included in survival analysis.
From: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients
| Clinical variable | Categories | Number of patients |
|---|---|---|
| T stage | T1-2 | 399 |
| T3-4 | 40 | |
| N stage | Nodes uninvolved (N0) | 299 |
| Nodes involved (N1-2) | 139 | |
| Tumor grade | Low grade (1) | 60 |
| Intermediate or high grade (2-3) | 374 | |
| Our classifier (MAPS) | MAPS- | 229 |
| MAPS+ (Expressor) | 211 |
